Credit Suisse reported on Thursday that they have lowered their rating on biopharmaceutical company, Pfizer Inc.(PFE).
The firm has downgraded PFE from “Outperform” to “Neutral,” and has given the company a $29 price target. This price target suggests a 6% increase from the stock’s current price of $27.20.
Pfizer shares were down 19 cents, or -0.70% during Thursday morning trading. The stock has increased 29% in the past year.
The Bottom Line
Shares of Pfizer Inc.(PFE) have a 3.53% yield, based on Thursday morning’s price of $27.20.
Pfizer Inc.(PFE) is a “Recommended” dividend stock at this time, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here